Pro198Leu polymorphism in the glutathione peroxidase 1 gene contributes to diabetic peripheral neuropathy in type 2 diabetes patients
Materials Color fruit juice-Tomato ketchup potato chips-color chocolate-color sweet were purchased from local market in El-Ahsa in Saudi Arabia
Clinical evidence for treating T2D patients with ferroptosis-targeted therapy is still lacking
Popular GLP-1 Receptor Agonists Some of the well-known GLP-1 receptor agonists include: There are four GLP-1 agonist medicines approved by the Therapeutic Goods Administration (TGA) for use in Australia for the management of Type 2 Diabetes: dulaglutide (Trulicity) semaglutide (Ozempic) tirzepatide (Mounjaro) liraglutide (Saxenda)
Becker K, Tilley L, Vennerstrom JL, Roberts D, Rogerson S, et al
Gerland LM, Peyrol S, Lallemand C, Branche R, Magaud JP, Ffrench M